ADMA EBITDA | ADMA BIOLOGICS, INC.

ADMA BIOLOGICS, INC. (ADMA) EBITDA

2026-06-30: Basis Reported; EBITDA $54.15M; Operating income (m); Depreciation and amortization (m).
2026-03-31: Basis Reported; EBITDA $60.07M; Operating income (m); Depreciation and amortization (m).
2025-12-31: Basis Reported; EBITDA $64.75M; Operating income (m); Depreciation and amortization (m).
2025-09-30: Basis Reported; EBITDA $53.01M; Operating income (m); Depreciation and amortization (m).

Complete source-backed ebitda history.

Available history: 2013-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical EBITDA

EBITDA 3 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2026-06-30	Reported	$54.15M	(m)	(m)	(m)	(m)	$2.26M*	$29.54M*	(m)	$6.01M	$26.74M	$12.41M
2026-03-31	Reported	$60.07M	(m)	(m)	(m)	(m)	$2.54M	$58.25M	(m)	$2.60M	$26.74M	$11.80M
2025-12-31	Reported	$64.75M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2025-09-30	Reported	$53.01M	(m)	(m)	(m)	(m)	$14.37M*	$13.29M*	(m)	$1.53M	$21.78M	$11.09M
2025-06-30	Reported	$44.8M	(m)	(m)	(m)	(m)	$2.42M*	$21.14M*	(m)	$1.03M	$22.21M	$5.88M
2025-03-31	Reported	$36.78M	(m)	(m)	(m)	(m)	$4.70M	-$19.68M	(m)	$826.00K	$24.08M	$6.55M
2024-12-31	Reported	$40.32M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2024-09-30	Reported	$41.54M	(m)	(m)	(m)	(m)	$1.06M*	$25.03M*	(m)	$412.00K	$18.56M	$840.00K
2024-06-30	Reported	$41.1M	(m)	(m)	(m)	(m)	$2.07M*	$45.65M*	(m)	$560.00K	$16.61M	$3.79M
2024-03-31	Reported	$23.72M	(m)	(m)	(m)	(m)	$2.35M	-$2.22M	(m)	$450.00K	$15.64M	$595.00K
2023-12-31	Reported	$16.13M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2023-09-30	Reported	$10.59M	(m)	(m)	(m)	(m)	$757.00K*	$11.98M*	(m)	$596.00K	$14.73M	$0.00
2023-06-30	Reported	$1.43M	(m)	(m)	(m)	(m)	$872.00K*	-$6.06M*	(m)	$1.40M	$14.25M	$0.00
2023-03-31	Reported	$1.09M	(m)	(m)	(m)	(m)	$1.95M	-$14.72M	(m)	$855.00K	$14.51M	$0.00
2022-12-31	Reported	-$4.26M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2022-09-30	Reported	-$7.62M	(m)	(m)	(m)	(m)	$3.38M*	-$13.28M*	(m)	$1.04M	$12.89M	(m)
2022-06-30	Reported	-$7.67M	(m)	(m)	(m)	(m)	$3.94M*	-$12.83M*	(m)	$873.39K	$11.97M	(m)
2022-03-31	Reported	-$13.42M	(m)	(m)	(m)	(m)	$2.84M	-$26.01M	(m)	$624.11K	$13.70M	(m)
2021-12-31	Reported	-$11.79M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2021-09-30	Reported	-$13.24M	(m)	(m)	(m)	(m)	$2.79M*	-$13.41M*	(m)	$770.56K	$10.73M	(m)
2021-06-30	Reported	-$14.48M	(m)	(m)	(m)	(m)	$4.48M*	-$32.26M*	(m)	$1.16M	$10.44M	(m)
2021-03-31	Reported	-$14.06M	(m)	(m)	(m)	(m)	$2.57M	-$33.23M	(m)	$987.65K	$10.03M	(m)
2020-12-31	Reported	-$16.22M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2020-09-30	Reported	-$12.9M	(m)	(m)	(m)	(m)	$2.89M*	-$23.85M*	(m)	$1.71M	$9.12M	(m)
2020-06-30	Reported	-$16.42M	(m)	(m)	(m)	(m)	$4.17M*	-$21.28M*	(m)	$1.66M	$8.70M	(m)
2020-03-31	Reported	-$16.17M	(m)	(m)	(m)	(m)	$2.07M	-$24.65M	(m)	$1.53M	(m)	(m)
2019-09-30	Reported	(m)	-$9.05M	(m)	(m)	(m)	$2.46M*	-$23.63M*	(m)	$491.40K	(m)	(m)
2019-06-30	Reported	(m)	-$11.34M	(m)	(m)	(m)	-$356.13K*	-$18.62M*	(m)	$516.99K	(m)	(m)
2019-03-31	Reported	(m)	-$13.21M	(m)	(m)	(m)	$110.45K	-$14.29M	(m)	$870.63K	(m)	(m)
2018-12-31	Reported	(m)	-$16.55M	(m)	(m)	(m)	(m)	(m)	(m)	$917.30K	(m)	(m)
2018-09-30	Reported	(m)	-$13.79M	(m)	(m)	(m)	$230.22K*	-$12.54M*	(m)	$1.00M	(m)	(m)
2018-06-30	Reported	(m)	-$13.42M	(m)	(m)	(m)	$497.13K*	-$14.91M*	(m)	$1.04M	(m)	(m)
2018-03-31	Reported	(m)	-$16.53M	(m)	(m)	(m)	$549.25K	-$16.43M	(m)	$965.57K	(m)	(m)
2017-09-30	Reported	(m)	-$14.43M	(m)	(m)	(m)	$569.90K*	-$9.74M*	(m)	$1.81M	(m)	(m)
2017-06-30	Reported	(m)	-$8.40M	(m)	(m)	(m)	$92.97K*	-$8.78M*	(m)	$1.36M	(m)	(m)
2017-03-31	Reported	(m)	-$5.94M	(m)	(m)	(m)	$3.58K	-$5.40M	(m)	$1.19M	(m)	(m)
2016-09-30	Reported	(m)	-$3.74M	(m)	(m)	(m)	$5.35K*	-$4.68M*	(m)	$1.68M	(m)	(m)
2016-06-30	Reported	(m)	-$5.49M	(m)	(m)	(m)	$40.60K*	-$4.80M*	(m)	$3.40M	(m)	(m)
2016-03-31	Reported	(m)	-$4.16M	(m)	(m)	(m)	$17.44K	-$5.17M	(m)	$2.03M	(m)	(m)
2015-09-30	Reported	(m)	-$4.66M	(m)	(m)	(m)	$8.88K*	-$2.67M*	(m)	$2.11M	(m)	(m)
2015-06-30	Reported	(m)	-$3.52M	(m)	(m)	(m)	$7.51K*	-$4.45M*	(m)	$1.51M	(m)	(m)
2015-03-31	Reported	(m)	-$3.20M	(m)	(m)	(m)	$14.19K	-$4.22M	(m)	$1.40M	(m)	(m)
2014-09-30	Reported	(m)	-$3.04M	(m)	(m)	(m)	$1.40M*	-$2.47M*	(m)	$1.48M	(m)	(m)
2014-06-30	Reported	(m)	-$3.59M	(m)	(m)	(m)	$258.54K*	-$4.30M*	(m)	$1.78M	(m)	(m)
2014-03-31	Reported	(m)	-$5.68M	(m)	(m)	(m)	$111.95K	-$5.04M	(m)	$4.33M	(m)	(m)
2013-09-30	Reported	(m)	-$2.53M	(m)	(m)	(m)	$16.37K*	-$2.23M*	(m)	$1.41M	(m)	(m)
2013-06-30	Reported	(m)	-$4.84M	(m)	(m)	(m)	$108.73K*	-$2.63M*	(m)	$3.47M	(m)	(m)
2013-03-31	Reported	(m)	-$3.15M	(m)	(m)	(m)	$66.07K	-$3.07M	(m)	$1.47M	(m)	(m)
2012-09-30	Reported	(m)	-$3.25M	(m)	(m)	(m)	$27.37K*	-$2.05M*	(m)	$1.94M	(m)	(m)
2012-06-30	Reported	(m)	-$1.21M	(m)	(m)	(m)	$56.15K*	-$1.04M*	(m)	$178.67K	(m)	(m)
2012-03-31	Reported	(m)	-$1.21M	(m)	(m)	(m)	$0.00	-$2.00M	(m)	$81.82K	(m)	(m)
2011-09-30	Reported	(m)	-$768.16K	(m)	(m)	(m)	(m)	-$5.18K	(m)	$56.61K	(m)	(m)
2011-06-30	Reported	(m)	-$2.15M	(m)	(m)	(m)	(m)	-$540.84K*	(m)	$139.68K	(m)	(m)
2011-03-31	Reported	(m)	-$1.59M	(m)	(m)	(m)	(m)	-$445.12K	(m)	$246.90K	(m)	(m)

EBITDA 12 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2025-12-31	Reported	$199.44M	(m)	(m)	(m)	(m)	$22.57M	$50.40M	(m)	$4.76M	$91.58M	$35.73M
2024-12-31	Reported	$146.68M	(m)	(m)	(m)	(m)	$8.23M	$118.67M	(m)	$1.81M	$74.12M	-$71.96M
2023-12-31	Reported	$29.23M	(m)	(m)	(m)	(m)	$4.77M	$8.80M	(m)	$3.30M	$59.02M	$0.00
2022-12-31	Reported	-$32.97M	(m)	(m)	(m)	(m)	$13.91M	-$59.51M	(m)	$3.61M	$52.46M	$0.00
2021-12-31	Reported	-$53.57M	(m)	(m)	(m)	(m)	$13.51M	-$112.37M	(m)	$3.65M	$42.90M	$0.00
2020-12-31	Reported	-$61.71M	(m)	(m)	(m)	(m)	$12.73M	-$102.00M	(m)	$5.91M	$35.05M	$0.00
2019-12-31	Reported	-$39.02M	(m)	(m)	(m)	(m)	$3.81M	-$76.19M	(m)	$2.34M	(m)	$0.00
2019-09-30	Rolling	(m)	-$50.15M*	(m)	(m)	(m)	(m)	(m)	(m)	$2.80M*	(m)	(m)
2019-06-30	Rolling	(m)	-$54.89M*	(m)	(m)	(m)	(m)	(m)	(m)	$3.31M*	(m)	(m)
2019-03-31	Rolling	(m)	-$56.96M*	(m)	(m)	(m)	(m)	(m)	(m)	$3.83M*	(m)	(m)
2018-12-31	Reported	-$57.69M	(m)	(m)	(m)	(m)	$2.10M	-$62.68M	(m)	$3.93M	(m)	$0.00
2018-12-31	Rolling	(m)	-$60.29M*	(m)	(m)	(m)	(m)	(m)	(m)	$3.93M*	(m)	(m)
2017-12-31	Reported	-$37.81M	(m)	(m)	(m)	(m)	$2.68M	-$37.27M	(m)	$5.57M	(m)	$0.00
2016-12-31	Reported	-$16.93M	(m)	(m)	(m)	(m)	$73.41K	-$18.27M	(m)	$7.69M	(m)	$0.00
2015-12-31	Reported	-$15.04M	(m)	(m)	(m)	(m)	$26.07K	-$15.42M	(m)	$7.02M	(m)	$0.00
2014-12-31	Reported	-$15.77M	(m)	(m)	(m)	(m)	$2.32M	-$14.70M	(m)	$9.52M	(m)	-$551.72K
2013-12-31	Reported	-$14.83M	(m)	(m)	(m)	(m)	$196.63K	-$10.89M	(m)	$9.30M	(m)	$0.00
2012-12-31	Reported	(m)	-$7.91M	(m)	(m)	(m)	$118.85K	-$6.90M	(m)	$3.47M	(m)	-$617.62K
2011-12-31	Reported	(m)	-$4.62M	(m)	(m)	(m)	$270.00	-$1.43M	(m)	$646.76K	(m)	(m)

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Kodiak Sciences Inc. (KOD)	United States	$2.090B	-10.12
BIOCRYST PHARMACEUTICALS INC (BCRX)	United States	$2.175B	-6.63
RECURSION PHARMACEUTICALS, INC. (RXRX)	United States	$2.080B	-3.78
Vericel Corp (VCEL)	United States	$2.011B	93.97
Greenland Mines Ltd (GRML)	United States	$2.362B
Vir Biotechnology, Inc. (VIR)	United States	$1.814B	-6.85
NOVAVAX INC (NVAX)	United States	$1.748B	-6.26
Beam Therapeutics Inc. (BEAM)	United States	$2.549B	-41.51
Hemab Therapeutics Holdings, Inc. (COAG)	United States	$1.672B
Immunocore Holdings plc (IMCR)		$1.613B	-90.43